Kolexia
Re Daniel Oncologie hémato.
Re Daniel
Oncologie hémato.
Centre Hospitalier de Antibes
Antibes, France
82 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Leucémies Leucémie aigüe myéloïde COVID-19 Leucémie chronique lymphocytaire à cellules B Lymphome malin non hodgkinien Leucémie lymphoïde Syndromes myélodysplasiques Tumeurs hématologiques

Collaborateurs

Voir plus
Gastaud Lauris
Gastaud Lauris
Centre Antoine Lacassagne, Nice, France
Thyss Antoine
Thyss Antoine
Centre Antoine Lacassagne, Nice, France
Peyrade Frederic
Peyrade Frederic
Centre Antoine Lacassagne, Nice, France
Gutnecht Jean
Gutnecht Jean
Chi De Frejus Saint Raphael, Fréjus, France

Industries

Voir plus
A+A
70 collaboration(s)
Dernière en 2023
B3TSI
39 collaboration(s)
Dernière en 2023
M3 Global Research Ltd
24 collaboration(s)
Dernière en 2021
Janssen
15 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
BRUIN-CLL-314: A Phase 3 Open-Label, Randomized Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN-CLL-314)
Essai Clinique (Loxo Oncology, Inc.)   24 janvier 2024
Humoral and cellular responses after a third dose of SARS-CoV-2 mRNA vaccine in patients with glomerular disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association   25 janvier 2023
Retreatment of Patients with Anti CD38-Based Combinations in Multiple Myeloma in Real-Life: Results from the Emmy Cohort Study
Annual Meeting Abstracts 2022   15 novembre 2022
The evolution of mature cystic teratomas of the ovary into squamous cell carcinoma: two case reports and review of the literature.
Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology   28 février 2022
Humoral and cellular responses after a third dose of SARS-CoV-2 BNT162b2 vaccine in patients with lymphoid malignancies.
Nature communications   14 février 2022
Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position article.
European journal of cancer (Oxford, England : 1990)   16 décembre 2021
Safety and Efficacy of Venetoclax-Based Treatment in Elderly CLL Patients: A Retrospective Study from the Filo Group
Blood   23 novembre 2021
Low rate of seroconversion after mRNA anti-SARS-CoV-2 vaccination in patients with hematological malignancies.
Leukemia & lymphoma   26 juillet 2021
Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer.
European journal of cancer (Oxford, England : 1990)   18 juin 2021
Autoimmune haemolytic anaemia associated with COVID-19 infection.
British journal of haematology   27 mai 2020